Skip to content
Stop using now Drug recall · FDA · Published October 16, 2025

Amerisource Health Recalls Prazosin Capsules Due to Carcinogenic Impurity Risk

Amerisource Health recalls 5mg Prazosin capsules with N-nitroso impurity above safety limits. This may increase cancer risk. Stop using and contact for return.

🇺🇸 FDA recall #D-0103-2026DrugAmerisource Health ›
Take action

Contact the company

Recalling firmAmerisource Health Services LLC2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

What happened, in plain English

Amerisource Health is recalling 5mg Prazosin capsules that contain a harmful impurity linked to cancer risk. This affects prescription-only medication sold with specific lot numbers and expiration dates. Read more at govinfonow.com/recall/31690-amerisource-health-recalls-prazosin-capsules-due-to-carcinogenic-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31690-amerisource-health-recalls-prazosin-capsules-due-to-carcinogenic-impurity-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0103-2026

Cite this page

“Amerisource Health Recalls Prazosin Capsules Due to Carcinogenic Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31690-amerisource-health-recalls-prazosin-capsules-due-to-carcinogenic-impurity-risk. Based on FDA recall #D-0103-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0103-2026%22&limit=1).

Why it’s dangerous

The capsules contain N-nitroso Prazosin impurities at levels above the acceptable safety limit. This impurity has been linked to increased cancer risk, making the product potentially harmful when taken as directed.

Who’s affected

Prescription patients who received the recalled Prazosin capsules with lot numbers 1016996, 1018336, 1021220 (expiring 11/30/2025) or 1022421, 1025017 (expiring 08/31/2026). Patients using these capsules for hypertension or other conditions are most at risk.

How to tell if you have this one

Check the carton for NDC 60687-572-32 and lot numbers 1016996, 1018336, 1021220 (expiring 11/30/2025) or 1022421, 1025017 (expiring 08/31/2026). The product is prescription-only and sold in 20-capsule cartons.

  • Brand
    Amerisource Health
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide within the United States
Recall numberProduct, codes & lotsQuantityNDC
D-0101-2026Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC 68084-996-01. Individual unit dose: NDC 68084-996-11; Lot #: 1023526, 1023555, Expiry: 07/31/20261,970 cartons68084-996-11, 68084-996-01, 68084-997-11, 68084-997-01
D-0102-2026Prazosin Hydrochloride, Capsules, USP, 2 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC 68084-997-01, Individual unit dose: NDC 68084-997-11; Lot #: 1020109, Exp. Date 02/28/2026; 1024343, 1025355, Exp. Date 09/30/2026.1,818 cartons68084-996-11, 68084-996-01, 68084-997-11, 68084-997-01
D-0103-2026Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, carton NDC 60687-572-32, Individual unit dose: NDC 60687-572-33; Lot #: 1016996, 1018336, 1021220, Exp. Date 11/30/2025; 1022421, 1025017, Exp. Date 08/31/2026.3,410 cartons60687-572-33, 60687-572-32
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop taking the recalled Prazosin capsules and do not use them.

  2. Contact for Return

    Contact Amerisource Health directly to arrange a safe return of the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 20 days after the firm started it.

1. Firm started the recall: Oct 16, 202512. FDA classified it Class II: Oct 24, 202523. Published in FDA’s Enforcement Report: Nov 5, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Amerisource Health recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0103-2026 (October 16, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0103-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA